CY1121643T1 - Ενα τροποποιημενο κολλαγονο - Google Patents

Ενα τροποποιημενο κολλαγονο

Info

Publication number
CY1121643T1
CY1121643T1 CY20191100545T CY191100545T CY1121643T1 CY 1121643 T1 CY1121643 T1 CY 1121643T1 CY 20191100545 T CY20191100545 T CY 20191100545T CY 191100545 T CY191100545 T CY 191100545T CY 1121643 T1 CY1121643 T1 CY 1121643T1
Authority
CY
Cyprus
Prior art keywords
collagen
modified collagen
modified
isolated
maturing
Prior art date
Application number
CY20191100545T
Other languages
English (en)
Inventor
Michael Myers
Alexandra DIETRICH
Original Assignee
Innocoll Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20120150527 external-priority patent/EP2612888A1/en
Priority claimed from GBGB1220868.2A external-priority patent/GB201220868D0/en
Application filed by Innocoll Pharmaceuticals Limited filed Critical Innocoll Pharmaceuticals Limited
Publication of CY1121643T1 publication Critical patent/CY1121643T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με ένα τροποποιημένο κολλαγόνο το οποίο μπορεί να ληφθεί με παροχή απομονωμένου κολλαγόνου• κατάψυξη του απομονωμένου κολλαγόνου• αφυδάτωση του κατεψυγμένου κολλαγόνου• και ωρίμανση του αφυδατωμένου κολλαγόνου. Επίσης γνωστοποιούνται μέθοδοι παρασκευής του τροποποιημένου κολλαγόνου και χρήσεις αυτού.
CY20191100545T 2012-01-09 2019-05-22 Ενα τροποποιημενο κολλαγονο CY1121643T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP20120150527 EP2612888A1 (en) 2012-01-09 2012-01-09 A modified collagen
GBGB1220868.2A GB201220868D0 (en) 2012-11-20 2012-11-20 A modified collagen
PCT/EP2013/050333 WO2013104687A2 (en) 2012-01-09 2013-01-09 A modified collagen
EP13700286.1A EP2802624B1 (en) 2012-01-09 2013-01-09 A modified collagen

Publications (1)

Publication Number Publication Date
CY1121643T1 true CY1121643T1 (el) 2020-07-31

Family

ID=47559477

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20171101134T CY1119524T1 (el) 2012-01-09 2017-10-31 Ena τροποποιημενο κολλαγονο
CY20191100545T CY1121643T1 (el) 2012-01-09 2019-05-22 Ενα τροποποιημενο κολλαγονο
CY20211100346T CY1124160T1 (el) 2012-01-09 2021-04-21 Ενα τροποποιημενο κολλαγονο

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20171101134T CY1119524T1 (el) 2012-01-09 2017-10-31 Ena τροποποιημενο κολλαγονο

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20211100346T CY1124160T1 (el) 2012-01-09 2021-04-21 Ενα τροποποιημενο κολλαγονο

Country Status (21)

Country Link
US (4) US10487134B2 (el)
EP (4) EP3901218A1 (el)
JP (3) JP6494285B2 (el)
AU (1) AU2013208952B2 (el)
CA (1) CA2860552C (el)
CY (3) CY1119524T1 (el)
DK (3) DK3536748T3 (el)
EA (2) EA037396B1 (el)
ES (3) ES2645445T3 (el)
HK (1) HK1244296B (el)
HR (3) HRP20171635T1 (el)
HU (3) HUE037043T2 (el)
LT (3) LT3255106T (el)
MX (1) MX368037B (el)
NO (1) NO2802624T3 (el)
PL (3) PL3255106T3 (el)
PT (2) PT3255106T (el)
RS (3) RS56564B1 (el)
SI (3) SI3536748T1 (el)
TR (1) TR201907156T4 (el)
WO (1) WO2013104687A2 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE037043T2 (hu) * 2012-01-09 2018-08-28 Innocoll Pharm Ltd Módosított kollagén
US20180237259A1 (en) * 2017-02-22 2018-08-23 Otis Elevator Company Method for detecting trapped passengers in elevator car
RU2704248C1 (ru) * 2018-10-02 2019-10-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") Способ получения пористого коллагенового материала
RU2760326C1 (ru) * 2021-03-04 2021-11-24 Общество с ограниченной ответственностью научно-производственное объединение «Велис» Способ получения пористого влагоемкого материала на коллагеновой основе
WO2022219009A1 (en) 2021-04-12 2022-10-20 Innocoll Pharmaceuticals Limited Drug-release implant for laparoscopic surgery
CN113201569B (zh) * 2021-06-21 2022-08-30 江南大学 一种牛ⅰ型胶原蛋白的纯化方法
IL310517A (en) * 2021-07-28 2024-03-01 Innocoll Pharm Ltd Bupivacaine-collagen drug delivery implant and methods for its preparation and use
WO2023084005A1 (en) * 2021-11-12 2023-05-19 Innocoll Pharmaceuticals Limited Resorbable collagen scaffold for dural repair
WO2024079289A1 (en) 2022-10-12 2024-04-18 Innocoll Pharmaceuticals Limited A kit for implanting a drug-release implant for laparoscopic surgery

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5246282B2 (el) * 1972-11-15 1977-11-24
US4097234A (en) * 1976-12-10 1978-06-27 Nippi, Incorporated Method for preparing dispersion of collagen fiber
US4279812A (en) * 1979-09-12 1981-07-21 Seton Company Process for preparing macromolecular biologically active collagen
US5206028A (en) 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
FR2720945B1 (fr) * 1994-06-08 1996-08-30 Coletica Membrane collagénique anti-adhérence post-opératoire.
US5945125A (en) 1995-02-28 1999-08-31 Temple University Controlled release tablet
AU716137B2 (en) * 1997-01-16 2000-02-17 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
US20010014667A1 (en) * 1998-01-05 2001-08-16 Chen Charles C. Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6682760B2 (en) * 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
NZ527046A (en) * 2001-01-16 2005-06-24 Vascular Therapies Llc A flexible cylindrical matrix material, preferably collagen with an antiproliferative agent preferably rapamycin dispersed throughout for implantation to be in contact with a vascular structure
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
JP2004099513A (ja) * 2002-09-09 2004-04-02 Toshiba Corp クラゲのコラーゲン回収方法及びクラゲのコラーゲン回収システム
WO2004090151A2 (en) * 2003-04-11 2004-10-21 Ecodynamic Biolab Inc. Method for extracting collagen comprising microbial fermentation
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
US8034368B2 (en) * 2007-03-28 2011-10-11 Innocoll Technologies Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
ES2718542T3 (es) 2007-03-28 2019-07-02 Innocoll Pharm Ltd Un dispositivo de suministro de medicamentos para proporcionar analgesia local, anestesia local o bloqueo nervioso
USRE47826E1 (en) * 2007-03-28 2020-01-28 Innocoll Pharmaceuticals Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US7820794B2 (en) * 2008-09-11 2010-10-26 Sunmax Biotechnology Co., Ltd. Long-lasting collagen and manufacturing method thereof
WO2010052694A2 (en) * 2008-11-06 2010-05-14 Innocoll Technologies Limited Drug delivery implants and processes for their preparation
CA2708844C (en) * 2009-07-27 2016-01-05 National Cheng Kung University Preparation of high purity collagen
JP2011225462A (ja) * 2010-04-16 2011-11-10 Ihara Suisan Kk 多孔質コラーゲン、その製造方法およびその用途
WO2011139228A1 (en) * 2010-05-07 2011-11-10 Empire Technology Development Llc Nano scale collagen particles and membranes
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
HUE037043T2 (hu) 2012-01-09 2018-08-28 Innocoll Pharm Ltd Módosított kollagén
US11623947B2 (en) * 2013-04-08 2023-04-11 Innocoll Pharmaceuticals Limited Collagen powder

Also Published As

Publication number Publication date
US20190359689A1 (en) 2019-11-28
PT2802624T (pt) 2017-11-10
HK1244296B (zh) 2020-06-05
ES2645445T3 (es) 2017-12-05
HRP20210699T1 (hr) 2021-09-17
EA027745B1 (ru) 2017-08-31
EA201790763A2 (ru) 2017-07-31
ES2870137T3 (es) 2021-10-26
HUE054838T2 (hu) 2021-10-28
RS56564B1 (sr) 2018-02-28
CY1124160T1 (el) 2022-05-27
EP2802624A2 (en) 2014-11-19
RS58935B1 (sr) 2019-08-30
EP3536748B1 (en) 2021-02-24
EP3901218A1 (en) 2021-10-27
PL3536748T3 (pl) 2021-07-19
US20170022266A1 (en) 2017-01-26
AU2013208952B2 (en) 2016-09-15
RS61726B1 (sr) 2021-05-31
EA201790763A3 (ru) 2017-11-30
JP2019065017A (ja) 2019-04-25
JP2020169188A (ja) 2020-10-15
PL3255106T3 (pl) 2019-09-30
US11746141B2 (en) 2023-09-05
ES2728205T3 (es) 2019-10-22
WO2013104687A2 (en) 2013-07-18
JP6494285B2 (ja) 2019-04-03
EP3255106B1 (en) 2019-04-24
DK3536748T3 (da) 2021-05-03
EP3255106A1 (en) 2017-12-13
EA201491278A1 (ru) 2015-01-30
EA037396B1 (ru) 2021-03-24
EP3536748A1 (en) 2019-09-11
WO2013104687A3 (en) 2013-12-05
HRP20171635T1 (hr) 2018-02-23
LT2802624T (lt) 2017-12-27
HUE043826T2 (hu) 2019-09-30
SI2802624T1 (en) 2018-02-28
US20150011476A1 (en) 2015-01-08
SI3536748T1 (sl) 2021-08-31
DK3255106T3 (da) 2019-05-20
US20220213173A1 (en) 2022-07-07
JP6720279B2 (ja) 2020-07-08
DK2802624T3 (da) 2017-11-13
JP7213205B2 (ja) 2023-01-26
CA2860552C (en) 2020-06-16
AU2013208952A1 (en) 2014-08-28
SI3255106T1 (sl) 2019-09-30
US10487134B2 (en) 2019-11-26
HRP20190861T1 (hr) 2019-08-09
PT3255106T (pt) 2019-06-04
LT3536748T (lt) 2021-08-10
MX368037B (es) 2019-09-17
TR201907156T4 (tr) 2019-06-21
EP2802624B1 (en) 2017-08-02
LT3255106T (lt) 2019-07-25
NO2802624T3 (el) 2017-12-30
JP2015508403A (ja) 2015-03-19
HUE037043T2 (hu) 2018-08-28
CY1119524T1 (el) 2018-03-07
PL2802624T3 (pl) 2018-02-28
CA2860552A1 (en) 2013-07-18
MX2014008327A (es) 2015-05-11

Similar Documents

Publication Publication Date Title
CY1124160T1 (el) Ενα τροποποιημενο κολλαγονο
CY1121862T1 (el) Αντισωματα anti-phf-tau και χρησεις αυτων
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CY1117956T1 (el) N3-αντικατεστημενα-n1-sulfonyl-5-fluoropyrimidinone παραγωγα
EA202092987A2 (ru) Липид, содержащий докозапентаеновую кислоту
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
EA201692425A1 (ru) Модифицированные биополимеры и способы их получения и использования
EP3038738A4 (en) Selective modification of polymer subunits to improve nanopore-based analysis
EP2900087A4 (en) PROCESS FOR THE PREPARATION OF FERMENTED IMP BROTH OR FERMENTED GLUTAMIC ACID BROTH AS A RAW MATERIAL FOR THE PREPARATION OF A NATURAL AROMA
BR112012030678A2 (pt) células-tronco da geleia de wharton nativa e sua purificação
SMT201500208B (it) Derivati di piridinone come inibitori della transglutaminasi tissutale
SK500072021U1 (sk) Prírodný vanilín
IL244949A0 (en) Natural fermentation of frozen dairy desserts using a natural plant source
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
EA201290623A1 (ru) Лактобациллы с антиоксидантным действием
UY36443A (es) Fibras de polipropileno mejoradas, métodos para su producción y usos de estas para la producción de productos de fibrocemento
MX2015009938A (es) Macromoleculas en forma de estrella tolerantes a las sales.
BR112014000460A2 (pt) método para produzir alimento seco
CY1121067T1 (el) Εμβολιο πεπτιδιου pcsk9
EA201690793A1 (ru) Способ получения лиофилизированной фармацевтической композиции, содержащей митомицин c
BR112015022234A2 (pt) nanopartículas de lípidos sólidos (ii)
EA201692347A1 (ru) Способ гидролиза лигноцеллюлозного материала, где гидролизат используют для получения микробной гидролазы
EA201500927A1 (ru) Твердые липидные наночастицы (i)
IN2013MU01290A (el)
CO7151534A2 (es) Endoglucanasas con propiedades mejoradas